Raleigh, NC, December 11, 2009 --(PR.com
)-- Nancy McFarlane, president of MedPro Rx, Inc. (www.medprorx.com), a provider of specialty pharmacy services to clients with chronic illnesses who need clotting factor, IVIg and other medication, has announced that applications are now open for their “Education Is Power” scholarship program. The annual scholarships are open to U.S. residents who are living with a bleeding disorder, entering or attending a community college, junior college, four-year college, university or vocational school, and active in their community. Application forms are available on MedPro Rx’s Web site, and they must be postmarked by May 1, 2010 to be eligible for consideration.
“Completing higher education plays a very important role in securing a successful future,” said McFarlane. “For people in the bleeding disorder community, having a good job not only means being successful, it means having health insurance that protects them from the financial burden of their condition.”
“The stories we have seen on the incoming applications have been inspirational,” said Kathy Robinette-Stoneberg, scholarship coordinator for MedPro Rx. “We are honored to help these students achieve their goals and fulfill their dreams.”
New Media Content:
2009-2010 Scholarship Details Podcast from Kathy Robinette-Stoneberg, MedPro Rx’s scholarship coordinator: http://www.medprorx.com/multimedia.html
- Since starting its “Education is Power” scholarship program in 2006, MedPro Rx has distributed $207,000 to students nationwide who have either hemophilia or von Willebrand Disease. In 2009, the pharmacy awarded 78 scholarships in 31 states totaling $72,000 for students living with bleeding disorders.
- A minimum of 20 scholarships will be awarded ranging in value from $500 to $2,500.
- People with hemophilia experience bleeding following an injury and may have frequent spontaneous bleeding episodes, often into the joints and muscles. More traumatic injuries may result in serious problems and potential disability. It is largely an inherited disorder, but in about 30 percent of cases there is no family history of the condition and it is the result of a spontaneous gene mutation. Approximately one in every 5,000 males nationwide is born with hemophilia, affecting all racial and socioeconomic groups equally. The three most common types of hemophilia are Hemophilia A or Factor VIII Deficiency, Hemophilia B or Factor IX Deficiency, and vWD.
- vWD is caused by a deficiency or defect of a clotting protein, and it affects approximately 1-2 percent of the United States population. Unlike hemophilia, vWD occurs equally among males and females and is more likely to cause nosebleeds and bleeding under the skin than into the joints.
- For more information about MedPro Rx’s “Education is Power” program or their pharmacy services, visit www.medprorx.com or call (888) 571-3100.
About MedPro RX, Inc.:
MedPro Rx, Inc. is a specialty infusion pharmacy which has been providing infused and injectable medications and services to clients with chronic illnesses since 2002. With more than 100 years of combined pharmacy, nursing and management experience, MedPro Rx is dedicated to improving the overall outcomes of the client therapy experience. MedPro Rx’s goal is to set the standard for infusion care and achieve positive clinical outcomes for clients by participating in the healthcare process through integrated, community-based systems. As a specialty infusion pharmacy, MedPro Rx is an Accreditation Commission for Health Care, Inc. provider (ACHC) whose services emphasize treatments for individuals with hemophilia, vWD, autoimmune neuromuscular disorders and other complex chronic conditions. Services include client and family advocacy, complimentary pick-up of sharps containers at the client’s location of choice, express shipping and personal medication delivery services, complete insurance and benefit counseling, and the assurance that MedPro Rx stocks all factor and IVIg brands, all doses from all manufacturers, all the time. MedPro Rx offers specialty intravenous therapies such as IVIg, which treats a variety of immunodeficient diagnoses, and clotting factor for clients to use in their home, at infusion clinics and in the physicians’ offices. For more information or to receive a free consultation and health insurance evaluation, please call (888) 571-3100 or visit www.medprorx.com.
MMI Public Relations